The Drug Enforcement Administration (DEA), together with the U.S. Department of Health and Human Services (HHS) published two final rules covering the prescription of controlled substances via telemedicine in limited contexts...more
Healthcare systems are facing significant challenges in recruiting and retaining talent within the burgeoning field of behavioral health services, primarily due to competition from telehealth providers and inconsistent...more
1/17/2024
/ Artificial Intelligence ,
Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Controlled Substances ,
Coronavirus/COVID-19 ,
DEA ,
Digital Health ,
Electronic Medical Records ,
Final Rules ,
Health Care Providers ,
Health Insurance ,
Healthcare Workers ,
Home Health Care ,
Medicare Advantage ,
Mental Health ,
Mental Illness ,
MHPAEA ,
Pediatrics ,
Physician Fee Schedule ,
Private Equity ,
Recruitment Incentives ,
Reimbursements ,
Telehealth
On July 25, 2023, the federal government introduced regulations and guidance aimed at improving adherence to the requirement that insurance companies must provide mental health and substance use disorder treatment benefits on...more
Earlier this year in late February, the Drug Enforcement Administration (DEA) announced proposed rules attempting to change the rules for tele-prescribing controlled drugs that were permitted during the COVID-19 Public Health...more
5/5/2023
/ American Medical Association ,
Controlled Substances ,
DEA ,
Department of Health and Human Services (HHS) ,
Electronic Prescribing ,
Health Care Providers ,
Prescription Drugs ,
Public Comment ,
Telehealth ,
Telemedicine ,
Temporary Regulations
Updated January 21, 2022 -
In response to the U.S. Supreme Court’s decision on January 13, 2022, upholding the Health Care Staff Vaccination Standards for certain Medicare- and Medicaid- certified providers and suppliers...more